AviadoBio is a biotechnology company developing transformative gene therapies for neurodegenerative disorders using a novel neuroanatomy-led approach to drug delivery.

Sectors
Healthcare
Life Sciences
First Invested
2021
Early
Company Status
Private
Associated Team
Matt McAviney, MD
Website
AviadoBio